The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
The agency determined that the potential of slowing the devastating disease in patients with mild cognitive impairment ...
The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second ...
Physicians who treat Alzheimer’s say the approval is an important step after decades of failed experimental treatments.
SARASOTA, Fla. (SNN) — The Food and Drug Administration has approved a new Alzheimer’s drug from Eli Lilly. According to Eli ...
The U.S. Food and Drug Administration on Tuesday gave a green light to Eli Lilly’s LLY.N donanemab for patients with early ...
The FDA has approved Eli Lilly's Alzheimer's drug that can slow memory decline. CONWAY GITTENS: I’m Conway Gittens reporting ...
The FDA approved Eli Lilly's Alzheimer's drug, expanding treatment options for the disease in the US. It will be sold under ...
Alzheimer’s drug that can slow the disease by several months. FDA approves a second Alzheimer’s drug that can slow the ...
It’s only the second drug that’s been convincingly shown to delay cognitive decline in patients, following last year’s ...
The FDA approved Eli Lilly's drug Kisunla to treat early-stage Alzheimer's disease. Kisunla is only the second drug approved ...
The Food and Drug Administration on Tuesday approved Eli Lilly’s Alzheimer’s drug, the company announced, clearing the way ...